Tobam Sells 224 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tobam lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 438 shares of the medical equipment provider’s stock after selling 224 shares during the quarter. Tobam’s holdings in Intuitive Surgical were worth $229,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. State Street Corp raised its holdings in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. FMR LLC raised its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares during the period. Geode Capital Management LLC boosted its holdings in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after acquiring an additional 143,440 shares in the last quarter. Fisher Asset Management LLC grew its stake in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after acquiring an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. increased its holdings in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,940 shares of company stock worth $3,333,485. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on ISRG shares. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG opened at $582.98 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock’s fifty day moving average price is $554.03 and its two-hundred day moving average price is $513.12. The firm has a market cap of $207.65 billion, a PE ratio of 90.95, a PEG ratio of 5.51 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.